Chaoju Eye Care Holdings Future Growth
Future criteria checks 3/6
Chaoju Eye Care Holdings is forecast to grow earnings and revenue by 14.1% and 14.1% per annum respectively. EPS is expected to grow by 14% per annum. Return on equity is forecast to be 11% in 3 years.
Key information
14.1%
Earnings growth rate
14.0%
EPS growth rate
Healthcare earnings growth | 16.2% |
Revenue growth rate | 14.1% |
Future return on equity | 11.0% |
Analyst coverage | Low |
Last updated | 08 Nov 2024 |
Recent future growth updates
Recent updates
Return Trends At Chaoju Eye Care Holdings (HKG:2219) Aren't Appealing
Sep 26Chaoju Eye Care Holdings' (HKG:2219) Upcoming Dividend Will Be Larger Than Last Year's
Jun 09Chaoju Eye Care Holdings (HKG:2219) Will Pay A Larger Dividend Than Last Year At CN¥0.2975
Apr 24Chaoju Eye Care Holdings' (HKG:2219) Solid Earnings Have Been Accounted For Conservatively
Apr 02Chaoju Eye Care Holdings (HKG:2219) Is Paying Out A Larger Dividend Than Last Year
Apr 01An Intrinsic Calculation For Chaoju Eye Care Holdings Limited (HKG:2219) Suggests It's 20% Undervalued
Jul 10Chaoju Eye Care Holdings (HKG:2219) Is Paying Out A Larger Dividend Than Last Year
Jun 07Earnings Report: Chaoju Eye Care Holdings Limited Missed Revenue Estimates By 7.9%
Mar 31A Look At The Fair Value Of Chaoju Eye Care Holdings Limited (HKG:2219)
Feb 28Chaoju Eye Care Holdings (HKG:2219) Could Be Struggling To Allocate Capital
Feb 06Chaoju Eye Care Holdings (HKG:2219) Is Reinvesting At Lower Rates Of Return
Aug 31We Think Chaoju Eye Care Holdings' (HKG:2219) Solid Earnings Are Understated
Apr 04Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 2,002 | 302 | N/A | 406 | 1 |
12/31/2025 | 1,794 | 287 | N/A | 392 | 2 |
12/31/2024 | 1,552 | 246 | N/A | 302 | 2 |
6/30/2024 | 1,411 | 215 | 279 | 352 | N/A |
3/31/2024 | 1,390 | 222 | 282 | 362 | N/A |
12/31/2023 | 1,370 | 229 | 286 | 373 | N/A |
9/30/2023 | 1,260 | 232 | 256 | 342 | N/A |
6/30/2023 | 1,150 | 235 | 226 | 311 | N/A |
3/31/2023 | 1,070 | 211 | 187 | 292 | N/A |
12/31/2022 | 990 | 188 | 148 | 273 | N/A |
9/30/2022 | 1,010 | 186 | 148 | 276 | N/A |
6/30/2022 | 1,030 | 184 | 149 | 279 | N/A |
3/31/2022 | 1,014 | 173 | 169 | 264 | N/A |
12/31/2021 | 998 | 162 | 189 | 249 | N/A |
9/30/2021 | 986 | 163 | 222 | 268 | N/A |
6/30/2021 | 975 | 164 | 256 | 287 | N/A |
3/31/2021 | 885 | 144 | 226 | 268 | N/A |
12/31/2020 | 794 | 124 | 196 | 249 | N/A |
12/31/2019 | 715 | 76 | 117 | 156 | N/A |
12/31/2018 | 633 | 39 | -8 | 90 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 2219's forecast earnings growth (14.1% per year) is above the savings rate (2.3%).
Earnings vs Market: 2219's earnings (14.1% per year) are forecast to grow faster than the Hong Kong market (11.5% per year).
High Growth Earnings: 2219's earnings are forecast to grow, but not significantly.
Revenue vs Market: 2219's revenue (14.1% per year) is forecast to grow faster than the Hong Kong market (7.7% per year).
High Growth Revenue: 2219's revenue (14.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 2219's Return on Equity is forecast to be low in 3 years time (11%).
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/23 22:20 |
End of Day Share Price | 2025/01/23 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Chaoju Eye Care Holdings Limited is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Yichi Zhang | China International Capital Corporation Limited |
null null | Guoyuan Securities (HK) Ltd |
Wen Dai | Huatai Research |